Our Team

Ideal background and experience in building businesses

David Reckeweg-Lecompte, Co-CEO, Co-Founder & Director (Germany)

David Reckeweg-Lecompte, Co-CEO, Co-Founder & Director (Germany)

CEO of Dr. Reckeweg, a German Pharma company with 75+ years in manufacturing plant-based medicinal products; partner of Eurox for Cannabis-extracted products; President of European Coalition on Homeopathic & Anthroposophic Medicinal Products (ECHAMP); MBA

Josh Gerstein, Co-CEO, Co-Founder & Director (Canada)

Josh Gerstein, Co-CEO, Co-Founder & Director (Canada)

Former executive of Canadian LP, through licensing, commissioning and sales stages; Merchant Banker & Corporate Strategist with extensive experience in private-public company transitions; MBA/JD

Bernhard Babel, President, Co-Founder & Director (Germany)

Bernhard Babel, President, Co-Founder & Director (Germany)

Co-Founder of Eurox, a medical Cannabis manufacturer in Europe; former Partner in McKinsey’s Regulatory & Strategy group, and CEO of McKinsey 100+ person division; PhD

Neil Smith, Chairman & Co-Founder (UK)

Neil Smith, Chairman & Co-Founder (UK)

Co-Founder of Eurox; former senior executive from Deutsche Bank overseeing 10,000+ employees; former consultant to McKinsey; held numerous board positions; track record of leading large & complex projects

Estela Figueiredo, Research & Product Development (Portugal)

Estela Figueiredo, Research & Product Development (Portugal)

EU QP; Master’s in analytical, clinical and forensic toxicology – Thesis focused on components of mushrooms and underlying soils; former production lead at Novartis

Dr. Carlos Ribeiro, Research & Product Development (Portugal)

Dr. Carlos Ribeiro, Research & Product Development (Portugal)

Research and product development in pharmaceutical engineering, medicinal chemistry and chemical biology; PhD in Pharmacy (Pharmaceutical and Therapeutic Chemistry)

Prof. Dr. Johannes Bartholomaeus, Product Development (Germany)

Prof. Dr. Johannes Bartholomaeus, Product Development (Germany)

Led pharmaceutical development and manufacturing of investigational medicinal products for Gruenenthal, a major German pharmaceutical player; PhD in Pharmaceutical Technology

Silvia Dickhut, Clinical Programs (Germany)

Silvia Dickhut, Clinical Programs (Germany)

25 years with Gruenenthal in drug development; multi-disciplinary expertise across research, technical (CMC) and clinical development, regulatory affairs, lifecycle management; M.Sc